SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-013529
Filing Date
2020-02-10
Accepted
2020-02-10 16:33:11
Documents
67
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1928371d1_10q.htm 10-Q 627079
2 EXHIBIT 10.47 tm1928371d1_ex10-47.htm EX-10.47 21387
3 EXHIBIT 10.48 tm1928371d1_ex10-48.htm EX-10.48 21773
4 EXHIBIT 31.1 tm1928371d1_ex31-1.htm EX-31.1 10336
5 EXHIBIT 31.2 tm1928371d1_ex31-2.htm EX-31.2 10215
6 EXHIBIT 32.1 tm1928371d1_ex32-1.htm EX-32.1 4484
  Complete submission text file 0001104659-20-013529.txt   5321047

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acur-20190630.xml EX-101.INS 1400710
8 XBRL TAXONOMY EXTENSION SCHEMA acur-20190630.xsd EX-101.SCH 44287
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20190630_cal.xml EX-101.CAL 39321
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20190630_def.xml EX-101.DEF 170476
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20190630_lab.xml EX-101.LAB 322761
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20190630_pre.xml EX-101.PRE 307539
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 20592389
SIC: 2834 Pharmaceutical Preparations